pyridinnukleotider
- (1)
- (1)
- (9)
- (3)
- (25)
- (2)
- (3)
- (2)
- (1)
- (1)
- (9)
- (1)
- (3)
- (3)
- (1)
- (7)
- (1)
- (3)
- (1)
- (2)
- (8)
- (1)
- (1)
- (3)
- (2)
- (7)
- (6)
- (3)
- (1)
- (3)
- (5)
- (2)
- (2)
- (1)
- (3)
- (1)
- (7)
- (12)
- (8)
- (11)
Filtrerade sökresultat
β-Nikotinamidadenindinukleotidhydrat, 98+%, Thermo Scientific Chemicals
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
beta-Nicotinamide adenine dinucleotide, 97%
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
β-Nikotinamid Adenin dinukleotid, oxiderad, fri syra, 99 %, MP Biomedicals™
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
β-Nikotinamid Adenin Dinukleotid, MP Biomedicals™
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
β-Nikotinamidadenindinukleotidfosfat, cellkulturreagens, MP Biomedicals™
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
β-Nikotinamid Adenin Dinukleotid, MP Biomedicals™
CAS: 53-84-9 Molekylformel: C21H27N7O14P2 Molekylvikt (g/mol): 663.43 MDL-nummer: MFCD00150377 InChI-nyckel: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] LEDER: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| Molekylformel | C21H27N7O14P2 |
|---|---|
| PubChem CID | 15938971 |
| MDL-nummer | MFCD00150377 |
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxioxolan-2-yl]metoxi-oxidofosforyl] [(2R,3S,4R,5R)-5-(3-karbamoylpyridin-1-ium-1-yl)-3,4-dihydroxi-oxolan-2-dioximetyl] |
| CAS | 53-84-9 |
| InChI-nyckel | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| LEDER | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| ChEBI | CHEBI:57540 |
| Molekylvikt (g/mol) | 663.43 |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
a-Nicotinamide Mononucleotide (>85%), TRC
CAS: 7298-94-4 Molekylformel: C11H15N2O8P Molekylvikt (g/mol): 334.22 Synonym: alpha-NMN,3-(Aminocarbonyl)-1-(5-O-phosphono-alpha-D-ribofuranosyl)pyridinium,((2R,3S,4R,5S)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Hydrogen Phosphate IUPAC-namn: [(2R,3S,4R,5S)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate LEDER: NC(=O)c1ccc[n+](c1)[C@H]2O[C@H](COP(=O)(O)[O-])[C@@H](O)[C@H]2O
| Molekylformel | C11H15N2O8P |
|---|---|
| IUPAC-namn | [(2R,3S,4R,5S)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate |
| CAS | 7298-94-4 |
| LEDER | NC(=O)c1ccc[n+](c1)[C@H]2O[C@H](COP(=O)(O)[O-])[C@@H](O)[C@H]2O |
| Molekylvikt (g/mol) | 334.22 |
| Synonym | alpha-NMN,3-(Aminocarbonyl)-1-(5-O-phosphono-alpha-D-ribofuranosyl)pyridinium,((2R,3S,4R,5S)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Hydrogen Phosphate |
Beta-Nicotinamide Mononucleotide, TRC
CAS: 1094-61-7 Molekylformel: C11 H15 N2 O8 P Molekylvikt (g/mol): 334.22 Synonym: Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-, inner salt,3-Carbamoyl-1-β-D-ribofuranosylpyridinium hydroxide, 5'-phosphate, inner salt (6CI,7CI),Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-, hydroxide, inner salt,Pyridinium, 3-carbamoyl-1-β-D-ribofuranosyl-, hydroxide, 5'-(dihydrogen phosphate), inner salt (8CI),NMN,NMN (mononucleotide),Nicotinamide mononucleotide,Nicotinamide ribonucleoside 5'-phosphate,Nicotinamide ribonucleotide,Nicotinamide ribotide,β-D-NMN,β-NMN,β-Nicotinamide mononucleotide IUPAC-namn: [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate LEDER: NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)[O-])[C@@H](O)[C@H]2O
| Molekylformel | C11 H15 N2 O8 P |
|---|---|
| IUPAC-namn | [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate |
| CAS | 1094-61-7 |
| LEDER | NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)[O-])[C@@H](O)[C@H]2O |
| Molekylvikt (g/mol) | 334.22 |
| Synonym | Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-, inner salt,3-Carbamoyl-1-β-D-ribofuranosylpyridinium hydroxide, 5'-phosphate, inner salt (6CI,7CI),Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)-, hydroxide, inner salt,Pyridinium, 3-carbamoyl-1-β-D-ribofuranosyl-, hydroxide, 5'-(dihydrogen phosphate), inner salt (8CI),NMN,NMN (mononucleotide),Nicotinamide mononucleotide,Nicotinamide ribonucleoside 5'-phosphate,Nicotinamide ribonucleotide,Nicotinamide ribotide,β-D-NMN,β-NMN,β-Nicotinamide mononucleotide |
Beta-Nicotinamide Adenine Dinucleotide, TRC
CAS: 53-84-9 Molekylformel: C21 H27 N7 O14 P2 Molekylvikt (g/mol): 663.42 Synonym: Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide, inner salt,β-NAD,Codehydrase I,Coenzyme I,Enzopride,Nadide,Nicotinamide-adenine dinucleotide IUPAC-namn: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate LEDER: NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O
| Molekylformel | C21 H27 N7 O14 P2 |
|---|---|
| IUPAC-namn | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate |
| CAS | 53-84-9 |
| LEDER | NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O |
| Molekylvikt (g/mol) | 663.42 |
| Synonym | Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide, inner salt,β-NAD,Codehydrase I,Coenzyme I,Enzopride,Nadide,Nicotinamide-adenine dinucleotide |
Nicotinamide riboside chloride, MedChemExpress
MedChemExpress Nicotinamide riboside Chloride, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside Chloride is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside Chloride reduces cognitive deterioration in a transgenic mouse model of Alzheimer’s disease.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
NADP sodium salt, MedChemExpress
MedChemExpress NADP sodium salt (Sodium NADP), a nicotinamide adenine dinucleotide, is a redox cofactor. NADP sodium salt is a key cofactor for electron transfer in the metabolism, being alternately oxidized (NADP+) and reduced (NADPH).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H27N7NaO17P3 |
|---|---|
| Rekommenderad förvaring | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 765.39 |
| Hållbarhet | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Hälsofara 1 | H319 |
| Löslighetsinformation | H2O : 100 mg/mL (130.65 mM; Need ultrasonic) ∣DMSO : 3.57 mg/mL (4.66 mM; ultrasonic and warming and heat to 80°C) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1184-16-3 |
| LEDER | NC1=C2C(N([C@H]3[C@H](OP(O)(O)=O)[C@H](O)[C@@H](COP(OP([O-])(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H]([N+]5=CC=CC(C(N)=O)=C5)O4)=O)([O-])=O)O3)C=N2)=NC=N1.[Na+] |
| Molekylvikt (g/mol) | 765.39 |
| Synonym | Sodium NADP |
| Kemiskt namn eller material | NADP sodium salt |
| Procent renhet | 98.0% |
Nicotinamide N-oxide, MedChemExpress
MedChemExpress Nicotinamide N-oxide, an in vivo nicotinamide metabolite, is a potent, and selective antagonist of the CXCR2 receptor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
NADP disodium salt, MedChemExpress
MedChemExpress NADP disodium salt (Disodium NADP), a nicotinamide adenine dinucleotide, is a redox cofactor. NADP disodium salt is a key cofactor for electron transfer in the metabolism, being alternately oxidized (NADP+) and reduced (NADPH).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H28N7O17P3.2Na |
|---|---|
| Rekommenderad förvaring | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 789.39 |
| Hållbarhet | -20°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | H2O : 250 mg/mL (316.70 mM; Need ultrasonic) ∣DMSO : 3.33 mg/mL (4.22 mM; ultrasonic and warming and heat to 80°C) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 24292-60-2 |
| LEDER | NC1=C2C(N([C@H]3[C@H](OP(O)(O)=O)[C@H](O)[C@@H](COP(OP([O-])(OC[C@@H]4[C@@H](O)[C@@H](O)[C@H]([N+]5=CC=CC(C(N)=O)=C5)O4)=O)(O)=O)O3)C=N2)=NC=N1.[2 Na] |
| Molekylvikt (g/mol) | 789.38 |
| Synonym | Disodium NADP |
| Kemiskt namn eller material | NADP disodium salt |
| Procent renhet | 98.47% |